澳大利亚妊娠中期妇女阴道特定细菌DNA特征可预测自发性早产高风险(Predict1000研究)
在澳大利亚珀斯招募1000名单胎妊娠妇女,于妊娠12至23周采集阴道拭子,用定量聚合酶链反应检测23种风险相关微生物DNA靶点。最终936名妇女中,自发性早产率6.2%;由阴道加德纳菌(clade 4)、惰性乳杆菌和微小脲原体(血清型3和6)DNA组成的特征可预测自发性早产,若加入具核梭杆菌检测则预测改善;仅自发性早产史预测优于该特征阳性(比值比3.6)。
要点
- 阴道卷曲乳杆菌、加氏乳杆菌或詹氏乳杆菌DNA较高者自发性早产率13.8% vs 足月31.2%(P=.005)。
- GLU检测预测<37周和≤34周自发性早产灵敏度分别为37.9%和44.4%,似然比分别为2.22/0.75和2.52/0.67。
- GLU阳性妇女胎膜早破风险增加逾两倍;仅自发性早产史预测优于GLU阳性(比值比3.6)。
核心结论
- 已识别出一种阴道细菌DNA特征,可识别单胎妊娠中自发性早产风险增加的妇女,这些妇女可能从靶向抗菌治疗中获益。
研究设计与样本
- 在澳大利亚珀斯招募1000名单胎妊娠妇女,于妊娠12至23周采集阴道中段拭子,用定量聚合酶链反应检测23种风险相关微生物DNA靶点,并记录产科病史、妊娠结局和人口学资料。
- 排除64名失访和样本不足者后,最终队列为936名妇女,以白人为主(74.3%)。
主要发现
- 总早产率为12.6%(118例);<37周自发性早产率为6.2%(≤34周为2.9%),未足月胎膜早破率为4.2%。
- 无单一微生物靶点可预测自发性早产风险增加;随后足月分娩的妇女阴道拭子中卷曲乳杆菌、加氏乳杆菌或詹氏乳杆菌DNA量较高(自发性早产13.8% vs 足月31.2%;P=.005)。
- 在其余妇女中,由阴道加德纳菌(clade 4)、惰性乳杆菌和微小脲原体(血清型3和6)DNA组成的特定微生物DNA特征可强烈预测自发性早产风险;若将具核梭杆菌检测纳入算法则风险预测改善。
- 最终算法称为阴道加德纳菌乳杆菌脲原体(GLU)检测,检测<37周和≤34周自发性早产风险的灵敏度分别为37.9%和44.4%,似然比(阳性/阴性)分别为2.22/0.75和2.52/0.67。
- GLU阳性妇女中未足月胎膜早破发生率是GLU阴性妇女的两倍以上;调整母亲人口学、种族和临床病史未改善预测;仅自发性早产史预测自发性早产优于GLU阳性结果(比值比3.6)。
临床怎么用
- 原文结论指出,该阴道细菌DNA特征可识别单胎妊娠中自发性早产风险增加的妇女,这些妇女可能从靶向抗菌治疗中获益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intrauterine infection accounts for a quarter of the cases of spontaneous preterm birth; however, at present, it is not possible to efficiently identify pregnant women at risk to deliver preventative treatments. OBJECTIVE: This study aimed to establish a vaginal microbial DNA test for Australian women in midpregnancy that will identify those at increased risk of spontaneous preterm birth. STUDY DESIGN: A total of 1000 women with singleton pregnancies were recruited in Perth, Australia. Midvaginal swabs were collected between 12 and 23 weeks' gestation. DNA was extracted for the detection of 23 risk-related microbial DNA targets by quantitative polymerase chain reaction. Obstetrical history, pregnancy outcome, and demographics were recorded. RESULTS: After excluding 64 women owing to losses to follow-up and insufficient sample for microbial analyses, the final cohort consisted of 936 women of predominantly white race (74.3%). The overall preterm birth rate was 12.6% (118 births); the spontaneous preterm birth rate at <37 weeks' gestation was 6.2% (2.9% at ≤34 weeks' gestation), whereas the preterm premature rupture of the membranes rate was 4.2%. No single individual microbial target predicted increased spontaneous preterm birth risk. Conversely, women who subsequently delivered at term had higher amounts of Lactobacillus crispatus, Lactobacillus gasseri, or Lactobacillus jensenii DNA in their vaginal swabs (13.8% spontaneous preterm birth vs 31.2% term; P=.005). In the remaining women, a specific microbial DNA signature was identified that was strongly predictive of spontaneous preterm birth risk, consisting of DNA from Gardnerella vaginalis (clade 4), Lactobacillus iners, and Ureaplasma parvum (serovars 3 and 6). Risk prediction was improved if Fusobacterium nucleatum detection was included in the test algorithm. The final algorithm, which we called the Gardnerella Lactobacillus Ureaplasma (GLU) test, was able to detect women at risk of spontaneous preterm birth at <37 and ≤34 weeks' gestation, with sensitivities of 37.9% and 44.4%, respectively, and likelihood ratios (plus or minus) of 2.22 per 0.75 and 2.52 per 0.67, respectively. Preterm premature rupture of the membranes was more than twice as common in GLU-positive women. Adjusting for maternal demographics, ethnicity, and clinical history did not improve prediction. Only a history of spontaneous preterm birth was more effective at predicting spontaneous preterm birth than a GLU-positive result (odds ratio, 3.6). CONCLUSION: We have identified a vaginal bacterial DNA signature that identifies women with a singleton pregnancy who are at increased risk of spontaneous preterm birth and may benefit from targeted antimicrobial therapy.
引用
- Payne MS, Newnham JP, Doherty DA, et al. A specific bacterial DNA signature in the vagina of Australian women in midpregnancy predicts high risk of spontaneous preterm birth (the Predict1000 study). Am J Obstet Gynecol. 2020. PMID: 32861687. doi:10.1016/j.ajog.2020.08.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。